|
|
SPOT ON
|
|
ASCOT Study: are new antihypertensives really any better?
|
|
Doubts about advantages of atorvastatin (SORTIS) in acute coronary syndrome
|
|
|
NEW ON THE MARKET
|
|
Anticonvulsive Zonisamide (ZONEGRAN)
|
|
|
THERAPIES FROM A CRITICAL VIEW POINT
|
|
N-acetylcysteine (e.g. FLUIMUCIL) without influence on natural course of COLD
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Beware of ORTHOKIN: factors produced by blood cells for osteoarthritis
Eflornithin (VANIQA) for treatment of hirsutism?
|
|
|
IN BRIEF
|
|
Hexavalent vaccine HEXAVAC off market
Traditional chinese medicine: Cave contamination
Parceoxib (DYNASTAT): not licensed in the US
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Thrombosis by quetiapine (SEROQUEL)
|
|
|
QUALITY CHECK
|
|
Allopurinol, amoxicillin, and naproxen products
|
|
|
SIDE EFFECTS
|
|
Suicidality by isotretinoin (e.g. ROACCUTAN)
|
|